United States · FDA National Drug Code directory
Galantamine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 65862-745_5b352114-093a-450c-81d1-4914dac5e2e3
- Product NDC
- 65862-745
- Form
- CAPSULE, EXTENDED RELEASE
- Composition / generic term
- Galantamine
- Labeler
- Aurobindo Pharma Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20160805
- Source listing expiry
- 20261231
Source-listed ingredients
- GALANTAMINE HYDROBROMIDE — 16 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (65862-745-01) · 65862-745-01
- 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (65862-745-05) · 65862-745-05
- 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (65862-745-30) · 65862-745-30
- 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (65862-745-90) · 65862-745-90
- 1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (65862-745-99) · 65862-745-99
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →